{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:50:38Z","timestamp":1789084238421,"version":"build-2803163510"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010580","name":"Department of Science and Technology, Hubei Provincial People\u2019s Government","doi-asserted-by":"publisher","award":["Q201810"],"award-info":[{"award-number":["Q201810"]}],"id":[{"id":"10.13039\/501100010580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-024-02335-9","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T08:01:48Z","timestamp":1721462508000},"page":"1339-1361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation"],"prefix":"10.1007","volume":"61","author":[{"given":"Xiaolei","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Alidadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vian","family":"Saed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firooze","family":"Sayyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Jadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Amraee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Jadidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8064-118X","authenticated-orcid":false,"given":"Reza","family":"Afrisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"issue":"1","key":"2335_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11892-003-0057-2","volume":"3","author":"JB Meigs","year":"2003","unstructured":"Meigs JB (2003) Epidemiology of the insulin resistance syndrome. Curr Diab Rep 3(1):73\u201379","journal-title":"Curr Diab Rep"},{"issue":"7785","key":"2335_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI (2019) The integrative biology of type 2 diabetes. Nature 576(7785):51\u201360","journal-title":"Nature"},{"issue":"Suppl 2","key":"2335_CR3","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109(Suppl 2):S135\u2013S148","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2335_CR4","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2021","unstructured":"Jensen-Cody SO, Potthoff MJ (2021) Hepatokines and metabolism: deciphering communication from the liver. Mol Metab 44:101138","journal-title":"Mol Metab"},{"issue":"5","key":"2335_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK (2019) The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev 40(5):1367\u20131393","journal-title":"Endocr Rev"},{"issue":"32","key":"2335_CR6","doi-asserted-by":"publisher","first-page":"e2309967120","DOI":"10.1073\/pnas.2309967120","volume":"120","author":"RC Adam","year":"2023","unstructured":"Adam RC, Pryce DS, Lee JS, Zhao Y, Mintah IJ, Min S et al (2023) Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice. Proc Natl Acad Sci U S A 120(32):e2309967120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2335_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cmet.2019.01.004","volume":"29","author":"SA Kliewer","year":"2019","unstructured":"Kliewer SA, Mangelsdorf DJ (2019) A dozen years of discovery: insights into the physiology and pharmacology of FGF21. Cell Metabol 29(2):246\u2013253","journal-title":"Cell Metabol"},{"key":"2335_CR8","unstructured":"Min L, Xiang J, Wang B, Ye C, Su X (2023) Novel insights of ANGPTL-3 on modulating cholesterol efflux Capacity Induced by HDL particle. Curr Mol Med"},{"key":"2335_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","volume":"64","author":"JA Siddiqui","year":"2022","unstructured":"Siddiqui JA, Pothuraju R, Khan P, Sharma G, Muniyan S, Seshacharyulu P et al (2022) Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth Factor Rev 64:71\u201383","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"2335_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pcd.2021.04.004","volume":"15","author":"N Govender","year":"2021","unstructured":"Govender N, Khaliq OP, Moodley J, Naicker T (2021) Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes 15(4):629\u2013634","journal-title":"Prim Care Diabetes"},{"key":"2335_CR11","doi-asserted-by":"crossref","unstructured":"Pei J, Wang B, Wang D (2022) Current studies on molecular mechanisms of insulin resistance. Journal of Diabetes Research. ;2022","DOI":"10.1155\/2022\/1863429"},{"issue":"1","key":"2335_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Park S-Y, Choi CS (2022) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metabolism J 46(1):15\u201337","journal-title":"Diabetes Metabolism J"},{"issue":"6865","key":"2335_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799\u2013806","journal-title":"Nature"},{"issue":"7","key":"2335_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23(7):804\u2013814","journal-title":"Nat Med"},{"issue":"8","key":"2335_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S et al (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18(8):1279\u20131285","journal-title":"Nat Med"},{"issue":"4","key":"2335_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nm.3116","volume":"19","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring H-U (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19(4):394\u2013395","journal-title":"Nat Med"},{"issue":"12","key":"2335_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman GI (2014) Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371(12):1131\u20131141","journal-title":"N Engl J Med"},{"issue":"2","key":"2335_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring H-U, White MF (2023) The role of hepatokines in NAFLD. Cell Metabol 35(2):236\u2013252","journal-title":"Cell Metabol"},{"issue":"10","key":"2335_CR19","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1016\/S0021-9258(19)39445-1","volume":"265","author":"AJ Cayatte","year":"1990","unstructured":"Cayatte AJ, Kumbla L, Subbiah MT (1990) Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. J Biol Chem 265(10):5883\u20135888","journal-title":"J Biol Chem"},{"issue":"22","key":"2335_CR20","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1042\/BCJ20210442","volume":"478","author":"D Chattopadhyay","year":"2021","unstructured":"Chattopadhyay D, Das S, Guria S, Basu S, Mukherjee S (2021) Fetuin-A regulates adipose tissue macrophage content and activation in insulin resistant mice through MCP-1 and iNOS: involvement of IFN\u03b3-JAK2-STAT1 pathway. Biochem J 478(22):4027\u20134043","journal-title":"Biochem J"},{"key":"2335_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-020-00540-4","volume":"12","author":"R Afrisham","year":"2020","unstructured":"Afrisham R, Sadegh-Nejadi S, Meshkani R, Emamgholipour S, Paknejad M (2020) Effect of circulating exosomes derived from normal-weight and obese women on gluconeogenesis, glycogenesis, lipogenesis and secretion of FGF21 and fetuin A in HepG2 cells. Diabetol Metab Syndr 12:1\u201311","journal-title":"Diabetol Metab Syndr"},{"key":"2335_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.intimp.2018.01.048","volume":"56","author":"N Wang","year":"2018","unstructured":"Wang N, Xu TY, Zhang X, Li JY, Wang YX, Guo XC et al (2018) Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes. Int Immunopharmacol 56:301\u2013309","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2335_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L (2014) Energy metabolism in the liver. Compr Physiol 4(1):177\u2013197","journal-title":"Compr Physiol"},{"issue":"6","key":"2335_CR24","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmet.2014.11.002","volume":"20","author":"SB Azimifar","year":"2014","unstructured":"Azimifar SB, Nagaraj N, Cox J, Mann M (2014) Cell-type-resolved quantitative proteomics of murine liver. Cell Metab 20(6):1076\u20131087","journal-title":"Cell Metab"},{"issue":"7502","key":"2335_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature13302","volume":"509","author":"MS Kim","year":"2014","unstructured":"Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R et al (2014) A draft map of the human proteome. Nature 509(7502):575\u2013581","journal-title":"Nature"},{"issue":"1","key":"2335_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3803\/EnM.2016.31.1.1","volume":"31","author":"KM Choi","year":"2016","unstructured":"Choi KM (2016) The impact of Organokines on insulin resistance, inflammation, and atherosclerosis. Endocrinol Metab (Seoul) 31(1):1\u20136","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"2335_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ (2017) Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol 13(9):509\u2013520","journal-title":"Nat Rev Endocrinol"},{"key":"2335_CR28","doi-asserted-by":"crossref","unstructured":"Carbone C, Piro G, Merz V, Simionato F, Santoro R, Zecchetto C et al (2018) Angiopoietin-like proteins in angiogenesis, inflammation and Cancer. Int J Mol Sci. ;19(2)","DOI":"10.3390\/ijms19020431"},{"issue":"1","key":"2335_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tcm.2007.10.003","volume":"18","author":"T Hato","year":"2008","unstructured":"Hato T, Tabata M, Oike Y (2008) The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 18(1):6\u201314","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2335_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","volume":"32","author":"SA Wu","year":"2021","unstructured":"Wu SA, Kersten S, Qi L (2021) Lipoprotein Lipase and its regulators: an Unfolding Story. Trends Endocrinol Metab 32(1):48\u201361","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2335_CR31","doi-asserted-by":"publisher","first-page":"E271","DOI":"10.1152\/ajpendo.90920.2008","volume":"297","author":"H Wang","year":"2009","unstructured":"Wang H, Eckel RH (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297(2):E271\u2013E288","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2335_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jcp.30534","volume":"237","author":"J Yang","year":"2022","unstructured":"Yang J, Song QY, Niu SX, Chen HJ, Petersen RB, Zhang Y et al (2022) Emerging roles of angiopoietin-like proteins in inflammation: mechanisms and potential as pharmacological targets. J Cell Physiol 237(1):98\u2013117","journal-title":"J Cell Physiol"},{"issue":"1","key":"2335_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jcp.30534","volume":"237","author":"J Yang","year":"2022","unstructured":"Yang J, Song Qy N, Sx C, Hj, Petersen RB, Zhang Y et al (2022) Emerging roles of angiopoietin-like proteins in inflammation: mechanisms and potential as pharmacological targets. J Cell Physiol 237(1):98\u2013117","journal-title":"J Cell Physiol"},{"issue":"2","key":"2335_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ijms19020431","volume":"19","author":"C Carbone","year":"2018","unstructured":"Carbone C, Piro G, Merz V, Simionato F, Santoro R, Zecchetto C et al (2018) Angiopoietin-like proteins in angiogenesis, inflammation and cancer. Int J Mol Sci 19(2):431","journal-title":"Int J Mol Sci"},{"issue":"21","key":"2335_CR35","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1158\/0008-5472.CAN-17-0579","volume":"77","author":"Q Yan","year":"2017","unstructured":"Yan Q, Jiang L, Liu M, Yu D, Zhang Y, Li Y et al (2017) ANGPTL1 interacts with integrin \u03b11\u03b21 to suppress HCC angiogenesis and metastasis by inhibiting JAK2\/STAT3 signaling. Cancer Res 77(21):5831\u20135845","journal-title":"Cancer Res"},{"issue":"5","key":"2335_CR36","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/hep.28773","volume":"64","author":"HA Chen","year":"2016","unstructured":"Chen HA, Kuo TC, Tseng CF, Ma JT, Yang ST, Yen CJ et al (2016) Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma. Hepatology 64(5):1637\u20131651","journal-title":"Hepatology"},{"issue":"3","key":"2335_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","volume":"10","author":"M Tabata","year":"2009","unstructured":"Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M et al (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metabol 10(3):178\u2013188","journal-title":"Cell Metabol"},{"key":"2335_CR38","doi-asserted-by":"crossref","unstructured":"Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y et al (2014) Role of endothelial cell\u2013derived Angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arteriosclerosis, thrombosis, and vascular biology. 34(4):790\u2013800","DOI":"10.1161\/ATVBAHA.113.303116"},{"issue":"3","key":"2335_CR39","doi-asserted-by":"publisher","first-page":"e000201","DOI":"10.1161\/JAHA.113.000201","volume":"2","author":"N Farhat","year":"2013","unstructured":"Farhat N, Thorin-Trescases N, Mamarbachi M, Villeneuve L, Yu C, Martel C et al (2013) Angiopoietin\u2010like 2 promotes atherogenesis in mice. J Am Heart Association 2(3):e000201","journal-title":"J Am Heart Association"},{"issue":"2","key":"2335_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF01222198","volume":"3","author":"M Nakamura","year":"1967","unstructured":"Nakamura M, Yamada K (1967) Studies on a diabetic (KK) strain of the mouse. Diabetologia 3(2):212\u2013221","journal-title":"Diabetologia"},{"issue":"2","key":"2335_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T et al (2002) Angptl3 regulates lipid metabolism in mice. Nat Genet 30(2):151\u2013157","journal-title":"Nat Genet"},{"issue":"37","key":"2335_CR42","doi-asserted-by":"publisher","first-page":"33742","DOI":"10.1074\/jbc.M203215200","volume":"277","author":"T Shimizugawa","year":"2002","unstructured":"Shimizugawa T, Ono M, Shimamura M, Yoshida K, Ando Y, Koishi R et al (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277(37):33742\u201333748","journal-title":"J Biol Chem"},{"issue":"7","key":"2335_CR43","doi-asserted-by":"publisher","first-page":"E1266","DOI":"10.1210\/jc.2012-1298","volume":"97","author":"I Minicocci","year":"2012","unstructured":"Minicocci I, Montali A, Robciuc MR, Quagliarini F, Censi V, Labbadia G et al (2012) Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab 97(7):E1266\u2013E1275","journal-title":"J Clin Endocrinol Metab"},{"issue":"37","key":"2335_CR44","doi-asserted-by":"publisher","first-page":"11630","DOI":"10.1073\/pnas.1515374112","volume":"112","author":"Y Wang","year":"2015","unstructured":"Wang Y, McNutt MC, Banfi S, Levin MG, Holland WL, Gusarova V et al (2015) Hepatic ANGPTL3 regulates adipose tissue energy homeostasis. Proc Natl Acad Sci U S A 112(37):11630\u201311635","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"2335_CR45","doi-asserted-by":"publisher","first-page":"41804","DOI":"10.1074\/jbc.M302861200","volume":"278","author":"M Ono","year":"2003","unstructured":"Ono M, Shimizugawa T, Shimamura M, Yoshida K, Noji-Sakikawa C, Ando Y et al (2003) Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 278(43):41804\u201341809","journal-title":"J Biol Chem"},{"issue":"1","key":"2335_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1194\/jlr.M200367-JLR200","volume":"44","author":"R Kaplan","year":"2003","unstructured":"Kaplan R, Zhang T, Hernandez M, Gan FX, Wright SD, Waters MG et al (2003) Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res 44(1):136\u2013143","journal-title":"J Lipid Res"},{"issue":"3","key":"2335_CR47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbrc.2004.08.024","volume":"322","author":"M Shimamura","year":"2004","unstructured":"Shimamura M, Matsuda M, Ando Y, Koishi R, Yasumo H, Furukawa H et al (2004) Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun 322(3):1080\u20131085","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2335_CR48","doi-asserted-by":"publisher","first-page":"e00160","DOI":"10.1042\/BSR20140115","volume":"34","author":"A Tikka","year":"2014","unstructured":"Tikka A, Soronen J, Laurila PP, Metso J, Ehnholm C, Jauhiainen M (2014) Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation. Biosci Rep 34(6):e00160","journal-title":"Biosci Rep"},{"issue":"5","key":"2335_CR49","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep.30030","volume":"68","author":"C Wang","year":"2018","unstructured":"Wang C, Tong Y, Wen Y, Cai J, Guo H, Huang L et al (2018) Hepatocellular carcinoma-associated protein TD26 interacts and enhances sterol regulatory element\u2010binding protein 1 activity to promote tumor cell proliferation and growth. Hepatology 68(5):1833\u20131850","journal-title":"Hepatology"},{"issue":"1","key":"2335_CR50","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1038\/s41598-018-25237-7","volume":"8","author":"E Biterova","year":"2018","unstructured":"Biterova E, Esmaeeli M, Alanen HI, Saaranen M, Ruddock LW (2018) Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease. Sci Rep 8(1):6752","journal-title":"Sci Rep"},{"issue":"3","key":"2335_CR51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4161\/adip.20787","volume":"1","author":"SK Koliwad","year":"2012","unstructured":"Koliwad SK, Gray NE, Wang JC (2012) Angiopoietin-like 4 (Angptl4): a glucocorticoid-dependent gatekeeper of fatty acid flux during fasting. Adipocyte 1(3):182\u2013187","journal-title":"Adipocyte"},{"key":"2335_CR52","doi-asserted-by":"publisher","first-page":"8187235","DOI":"10.1155\/2017\/8187235","volume":"2017","author":"L La Paglia","year":"2017","unstructured":"La Paglia L, List\u00ec A, Caruso S, Amodeo V, Passiglia F, Bazan V et al (2017) Potential role of ANGPTL4 in the Cross talk between metabolism and Cancer through PPAR signaling pathway. PPAR Res 2017:8187235","journal-title":"PPAR Res"},{"key":"2335_CR53","doi-asserted-by":"crossref","unstructured":"Singh AK, Chaube B, Zhang X, Sun J, Citrin KM, Canfr\u00e1n-Duque A et al (2021) Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice. J Clin Invest. ;131(17)","DOI":"10.1172\/JCI140989"},{"issue":"11","key":"2335_CR54","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","volume":"43","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Shimizugawa T, Ono M, Furukawa H (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43(11):1770\u20131772","journal-title":"J Lipid Res"},{"issue":"4","key":"2335_CR55","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3892\/mmr.2016.5637","volume":"14","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu LM, Wei L, Ye WW, Meng XY, Chen F et al (2016) Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice. Mol Med Rep 14(4):3293\u20133300","journal-title":"Mol Med Rep"},{"issue":"17","key":"2335_CR56","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1073\/pnas.0408452102","volume":"102","author":"A Xu","year":"2005","unstructured":"Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL et al (2005) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 102(17):6086\u20136091","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2335_CR57","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cyto.2018.05.030","volume":"111","author":"\u00d6 Altun","year":"2018","unstructured":"Altun \u00d6, Dikker O, Arman Y, Ugurlukisi B, Kutlu O, Ozgun Cil E et al (2018) Serum angiopoietin-like peptide 4 levels in patients with hepatic steatosis. Cytokine 111:496\u2013499","journal-title":"Cytokine"},{"issue":"6","key":"2335_CR58","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00011-023-01753-9","volume":"72","author":"Y Zuo","year":"2023","unstructured":"Zuo Y, He Z, Chen Y, Dai L (2023) Dual role of ANGPTL4 in inflammation. Inflamm Res 72(6):1303\u20131313","journal-title":"Inflamm Res"},{"key":"2335_CR59","doi-asserted-by":"crossref","unstructured":"Im Cho D, Kang H-j, Jeon JH, Eom GH, Cho HH, Kim MR et al (2019) Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair. JCI Insight. ;4(16)","DOI":"10.1172\/jci.insight.125437"},{"key":"2335_CR60","doi-asserted-by":"publisher","first-page":"461900","DOI":"10.3389\/fendo.2019.00495","volume":"10","author":"G Alghanim","year":"2019","unstructured":"Alghanim G, Qaddoumi MG, Alhasawi N, Cherian P, Al-Khairi I, Nizam R et al (2019) Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance. Front Endocrinol 10:461900","journal-title":"Front Endocrinol"},{"key":"2335_CR61","doi-asserted-by":"crossref","unstructured":"Fan KC, Wu HT, Wei JN, Chuang LM, Hsu CY, Yen IW et al (2020) Serum angiopoietin-like protein 6, risk of type 2 diabetes, and response to hyperglycemia: a prospective cohort study. J Clin Endocrinol Metab. ;105(5)","DOI":"10.1210\/clinem\/dgaa103"},{"issue":"3","key":"2335_CR62","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.107.127530","volume":"323","author":"M Kitazawa","year":"2007","unstructured":"Kitazawa M, Ohizumi Y, Oike Y, Hishinuma T, Hashimoto S (2007) Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt\/forkhead box class O1-dependent pathway in hepatocytes. J Pharmacol Exp Ther 323(3):787\u2013793","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2335_CR63","first-page":"781","volume":"14","author":"G Erkan","year":"2018","unstructured":"Erkan G, Muratoglu S, Ercin U, Bilgihan A (2018) Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease. Arch Med Sci 14(4):781\u2013787","journal-title":"Arch Med Sci"},{"issue":"1","key":"2335_CR64","doi-asserted-by":"publisher","first-page":"34690","DOI":"10.1038\/srep34690","volume":"6","author":"H Tanigawa","year":"2016","unstructured":"Tanigawa H, Miyata K, Tian Z, Aoi J, Kadomatsu T, Fukushima S et al (2016) Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis. Sci Rep 6(1):34690","journal-title":"Sci Rep"},{"issue":"5","key":"2335_CR65","doi-asserted-by":"publisher","first-page":"E613","DOI":"10.1152\/ajpendo.00339.2019","volume":"318","author":"L Zhang","year":"2020","unstructured":"Zhang L, Shannon CE, Bakewell TM, Abdul-Ghani MA, Fourcaudot M, Norton L (2020) Regulation of ANGPTL8 in liver and adipose tissue by nutritional and hormonal signals and its effect on glucose homeostasis in mice. Am J Physiol Endocrinol Metab 318(5):E613\u2013e24","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2335_CR66","doi-asserted-by":"publisher","first-page":"144707","DOI":"10.1016\/j.gene.2020.144707","volume":"749","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Wu H, Dai L, Yuan Y, Zhu Y, Ma Z et al (2020) ANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation. Gene 749:144707","journal-title":"Gene"},{"key":"2335_CR67","doi-asserted-by":"publisher","first-page":"635321","DOI":"10.3389\/fendo.2021.635321","volume":"12","author":"Y Bai","year":"2021","unstructured":"Bai Y, Du Q, Zhang L, Li L, Wang N, Wu B et al (2021) Silencing of ANGPTL8 alleviates insulin resistance in trophoblast cells. Front Endocrinol (Lausanne) 12:635321","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2335_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-023-01905-0","volume":"22","author":"S Saghafi","year":"2023","unstructured":"Saghafi S, Chamani E, Salmani F, Fadaei R, Shafiei E, Moradi N et al (2023) Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults. Lipids Health Dis 22(1):147","journal-title":"Lipids Health Dis"},{"key":"2335_CR69","doi-asserted-by":"publisher","first-page":"154921","DOI":"10.1016\/j.metabol.2021.154921","volume":"126","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Deng X, Jia J, Zhao L, Wang C, Cai Z et al (2022) Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K\/Akt signaling pathway in diabetic mice. Metabolism 126:154921","journal-title":"Metabolism"},{"issue":"3","key":"2335_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.15698\/cst2018.03.128","volume":"2","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zheng L, Huang K (2018) A new way to regulate inflammation: selective autophagic degradation of IKK\u03b3 mediated by ANGPTL8. Cell Stress 2(3):66","journal-title":"Cell Stress"},{"issue":"1","key":"2335_CR71","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/s41467-017-02355-w","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Guo X, Yan W, Chen Y, Ke M, Cheng C et al (2017) ANGPTL8 negatively regulates NF-\u03baB activation by facilitating selective autophagic degradation of IKK\u03b3. Nat Commun 8(1):2164","journal-title":"Nat Commun"},{"issue":"1","key":"2335_CR72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7150\/ijbs.73936","volume":"19","author":"H Tan","year":"2023","unstructured":"Tan H, Yue T, Chen Z, Wu W, Xu S, Weng J (2023) Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine. Int J Biol Sci 19(1):66\u201388","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2335_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.apsb.2012.06.011","volume":"2","author":"X Ge","year":"2012","unstructured":"Ge X, Wang Y, Lam KS, Xu A (2012) Metabolic actions of FGF21: molecular mechanisms and therapeutic implications. Acta Pharm Sinica B 2(4):350\u2013357","journal-title":"Acta Pharm Sinica B"},{"issue":"2","key":"2335_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","volume":"23","author":"S von Holstein-Rathlou","year":"2016","unstructured":"von Holstein-Rathlou S, BonDurant LD, Peltekian L, Naber MC, Yin TC, Claflin KE et al (2016) FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet taste preference by the liver. Cell Metab 23(2):335\u2013343","journal-title":"Cell Metab"},{"issue":"10","key":"2335_CR75","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1210\/en.2009-0119","volume":"150","author":"Y Hotta","year":"2009","unstructured":"Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S et al (2009) Fibroblast growth factor 21 regulates Lipolysis in White Adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150(10):4625\u20134633","journal-title":"Endocrinology"},{"key":"2335_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.canlet.2020.11.026","volume":"499","author":"W Lu","year":"2021","unstructured":"Lu W, Li X, Luo Y (2021) FGF21 in obesity and cancer: new insights. Cancer Lett 499:5\u201313","journal-title":"Cancer Lett"},{"issue":"2","key":"2335_CR77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cmet.2019.01.004","volume":"29","author":"SA Kliewer","year":"2019","unstructured":"Kliewer SA, Mangelsdorf DJ (2019) A Dozen years of Discovery: insights into the physiology and pharmacology of FGF21. Cell Metab 29(2):246\u2013253","journal-title":"Cell Metab"},{"issue":"1","key":"2335_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","volume":"38","author":"LD BonDurant","year":"2018","unstructured":"BonDurant LD, Potthoff MJ (2018) Fibroblast growth factor 21: a Versatile Regulator of metabolic homeostasis. Annu Rev Nutr 38(1):173\u2013196","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"2335_CR79","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","volume":"25","author":"LD BonDurant","year":"2017","unstructured":"BonDurant LD, Ameka M, Naber MC, Markan KR, Idiga SO, Acevedo MR et al (2017) FGF21 regulates metabolism through adipose-dependent and -independent mechanisms. Cell Metab 25(4):935\u201344e4","journal-title":"Cell Metab"},{"issue":"4","key":"2335_CR80","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","volume":"20","author":"BM Owen","year":"2014","unstructured":"Owen BM, Ding X, Morgan DA, Coate KC, Bookout AL, Rahmouni K et al (2014) FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab 20(4):670\u2013677","journal-title":"Cell Metab"},{"issue":"19","key":"2335_CR81","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1042\/CS20190093","volume":"133","author":"T Xie","year":"2019","unstructured":"Xie T, So WY, Li XY, Leung PS (2019) Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic \u03b2-cell dysfunction via regulation of AMPK signaling and lipid metabolism. Clin Sci (Lond) 133(19):2029\u20132044","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2335_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/hep.28523","volume":"64","author":"Q Gong","year":"2016","unstructured":"Gong Q, Hu Z, Zhang F, Cui A, Chen X, Jiang H et al (2016) Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Hepatology 64(2):425\u2013438","journal-title":"Hepatology"},{"issue":"22","key":"2335_CR83","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.1074\/jbc.M116.767590","volume":"292","author":"T Goto","year":"2017","unstructured":"Goto T, Hirata M, Aoki Y, Iwase M, Takahashi H, Kim M et al (2017) The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-\u03b1 agonist-induced amelioration of metabolic disorders in obese mice. J Biol Chem 292(22):9175\u20139190","journal-title":"J Biol Chem"},{"key":"2335_CR84","doi-asserted-by":"crossref","unstructured":"Al-Mansoori L, Al-Jaber H, Prince MS, Elrayess MA (2022) Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance. Inflammation. :1\u201314","DOI":"10.1007\/s10753-021-01559-z"},{"key":"2335_CR85","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s12272-020-01295-2","volume":"43","author":"D-L ZhuGe","year":"2020","unstructured":"ZhuGe D-L, Javaid HMA, Sahar NE, Zhao Y-Z, Huh JY (2020) Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation. Arch Pharm Res 43:1311\u20131324","journal-title":"Arch Pharm Res"},{"key":"2335_CR86","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-pharmtox-032322-093904","volume":"63","author":"L Jin","year":"2023","unstructured":"Jin L, Yang R, Geng L, Xu A (2023) Fibroblast growth factor-based pharmacotherapies for the treatment of obesity-related metabolic complications. Annu Rev Pharmacol Toxicol 63:359\u2013382","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2335_CR87","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","volume":"44","author":"SO Jensen-Cody","year":"2021","unstructured":"Jensen-Cody SO, Potthoff MJ (2021) Hepatokines and metabolism: deciphering communication from the liver. Mol Metabolism 44:101138","journal-title":"Mol Metabolism"},{"issue":"1","key":"2335_CR88","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbadis.2016.10.002","volume":"1863","author":"S Agarwal","year":"2017","unstructured":"Agarwal S, Chattopadhyay M, Mukherjee S, Dasgupta S, Mukhopadhyay S, Bhattacharya S (2017) Fetuin-A downregulates adiponectin through Wnt-PPAR\u03b3 pathway in lipid induced inflamed adipocyte. Biochim Biophys Acta Mol Basis Dis 1863(1):174\u2013181","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"2335_CR89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1515\/jbcr-2017-0015","volume":"10","author":"RS Komsa-Penkova","year":"2017","unstructured":"Komsa-Penkova RS, Golemanov GM, Radionova ZV, Tonchev PT, Iliev SD, Penkov VV (2017) Fetuin-A\u2013alpha2-heremans-schmid glycoprotein: from structure to a novel marker of chronic diseases part 1. Fetuin-A as a calcium chaperone and inflammatory marker. J Biomedical Clin Res 10(2):90\u201397","journal-title":"J Biomedical Clin Res"},{"issue":"1\u20132","key":"2335_CR90","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0303-7207(00)00237-9","volume":"164","author":"ST Mathews","year":"2000","unstructured":"Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS et al (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164(1\u20132):87\u201398","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2335_CR91","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0092-8674(89)90098-6","volume":"58","author":"P Auberger","year":"1989","unstructured":"Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B et al (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58(4):631\u2013640","journal-title":"Cell"},{"key":"2335_CR92","doi-asserted-by":"publisher","first-page":"945287","DOI":"10.3389\/fcell.2022.945287","volume":"10","author":"E Chekol Abebe","year":"2022","unstructured":"Chekol Abebe E, Tilahun Muche Z, Behaile TMA, Mengie Ayele T, Mekonnen Agidew M, Teshome Azezew M et al (2022) The structure, biosynthesis, and biological roles of fetuin-A: a review. Front Cell Dev Biol 10:945287","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2335_CR93","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kr\u00f6ber SM et al (2006) Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29(4):853\u2013857","journal-title":"Diabetes Care"},{"issue":"10","key":"2335_CR94","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.2337\/db08-0538","volume":"57","author":"N Stefan","year":"2008","unstructured":"Stefan N, Fritsche A, Weikert C, Boeing H, Joost H-G, H\u00e4ring H-U et al (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57(10):2762\u20132767","journal-title":"Diabetes"},{"issue":"6","key":"2335_CR95","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2337\/db17-1268","volume":"67","author":"J Kroeger","year":"2018","unstructured":"Kroeger J, Meidtner K, Stefan N, Guevara M, Kerrison ND, Ardanaz E et al (2018) Circulating fetuin-A and risk of type 2 diabetes: a mendelian randomization analysis. Diabetes 67(6):1200\u20131205","journal-title":"Diabetes"},{"issue":"2","key":"2335_CR96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jama.300.2.182","volume":"300","author":"JH Ix","year":"2008","unstructured":"Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A et al (2008) Fetuin-A and incident diabetes mellitus in older persons. JAMA 300(2):182\u2013188","journal-title":"JAMA"},{"issue":"3","key":"2335_CR97","doi-asserted-by":"publisher","first-page":"e1765","DOI":"10.1371\/journal.pone.0001765","volume":"3","author":"AM Hennige","year":"2008","unstructured":"Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, H\u00e4ring HU et al (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3(3):e1765","journal-title":"PLoS ONE"},{"issue":"9","key":"2335_CR98","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RC Meex","year":"2017","unstructured":"Meex RC, Watt MJ (2017) Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Reviews Endocrinol 13(9):509\u2013520","journal-title":"Nat Reviews Endocrinol"},{"key":"2335_CR99","doi-asserted-by":"crossref","unstructured":"Pan X, Kaminga AC, Chen J, Luo M, Luo J (2020) Fetuin-A and Fetuin-B in non-alcoholic fatty liver disease: a Meta-analysis and Meta-regression. Int J Environ Res Public Health. ;17(8)","DOI":"10.3390\/ijerph17082735"},{"issue":"12","key":"2335_CR100","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.4158\/EP14421.RA","volume":"20","author":"S Mukhopadhyay","year":"2014","unstructured":"Mukhopadhyay S, Mondal SA, Kumar M, Dutta D (2014) Proinflammatory and antiinflammatory attributes of fetuin-a: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome. Endocr Pract 20(12):1345\u20131351","journal-title":"Endocr Pract"},{"issue":"21","key":"2335_CR101","doi-asserted-by":"publisher","first-page":"jcs258507","DOI":"10.1242\/jcs.258507","volume":"134","author":"A Mukhuty","year":"2021","unstructured":"Mukhuty A, Fouzder C, Kundu R (2021) Fetuin-A secretion from \u03b2-cells leads to accumulation of macrophages in islets, aggravates inflammation and impairs insulin secretion. J Cell Sci 134(21):jcs258507","journal-title":"J Cell Sci"},{"issue":"41","key":"2335_CR102","doi-asserted-by":"publisher","first-page":"16239","DOI":"10.1073\/pnas.0705971104","volume":"104","author":"KL Jones","year":"2007","unstructured":"Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM et al (2007) Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104(41):16239\u201316244","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2335_CR103","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/biomedicines9080999","volume":"9","author":"OK Parfenova","year":"2021","unstructured":"Parfenova OK, Kukes VG, Grishin DV (2021) Follistatin-like proteins: structure, functions and biomedical importance. Biomedicines 9(8):999","journal-title":"Biomedicines"},{"issue":"6","key":"2335_CR104","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/dmrr.2415","volume":"29","author":"J Hansen","year":"2013","unstructured":"Hansen J, Rinnov A, Krogh-Madsen R, Fischer CP, Andreasen AS, Berg RM et al (2013) Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation. Diabetes Metab Res Rev 29(6):463\u2013472","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2335_CR105","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1038\/s41467-021-26536-w","volume":"12","author":"C Wu","year":"2021","unstructured":"Wu C, Born\u00e9 Y, Gao R, L\u00f3pez Rodriguez M, Roell WC, Wilson JM et al (2021) Elevated circulating follistatin associates with an increased risk of type 2 diabetes. Nat Commun 12(1):6486","journal-title":"Nat Commun"},{"issue":"2","key":"2335_CR106","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jc.2015-3668","volume":"101","author":"JS Hansen","year":"2016","unstructured":"Hansen JS, Rutti S, Arous C, Clemmesen JO, Secher NH, Drescher A et al (2016) Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio. J Clin Endocrinol Metab 101(2):550\u2013560","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2335_CR107","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1210\/en.2006-0089","volume":"147","author":"Y Sidis","year":"2006","unstructured":"Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A (2006) Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147(7):3586\u20133597","journal-title":"Endocrinology"},{"issue":"9","key":"2335_CR108","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/153537020222700905","volume":"227","author":"C Welt","year":"2002","unstructured":"Welt C, Sidis Y, Keutmann H, Schneyer A (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Experimental Biology Med 227(9):724\u2013752","journal-title":"Experimental Biology Med"},{"key":"2335_CR109","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2016.06.002","volume":"433","author":"JS Hansen","year":"2016","unstructured":"Hansen JS, Plomgaard P (2016) Circulating follistatin in relation to energy metabolism. Mol Cell Endocrinol 433:87\u201393","journal-title":"Mol Cell Endocrinol"},{"key":"2335_CR110","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.molmet.2023.101703","volume":"71","author":"R Tao","year":"2023","unstructured":"Tao R, St\u00f6hr O, Wang C, Qiu W, Copps KD, White MF (2023) Hepatic follistatin increases basal metabolic rate and attenuates diet-induced obesity during hepatic insulin resistance. Mol Metabolism 71:101703","journal-title":"Mol Metabolism"},{"issue":"16","key":"2335_CR111","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"S-J Lee","year":"2001","unstructured":"Lee S-J, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci 98(16):9306\u20139311","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2335_CR112","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cvr\/cvt173","volume":"100","author":"M Blumensatt","year":"2013","unstructured":"Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ et al (2013) Activin a impairs insulin action in cardiomyocytes via up-regulation of miR-143. Cardiovasc Res 100(2):201\u2013210","journal-title":"Cardiovasc Res"},{"key":"2335_CR113","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-800101-1.00005-3","volume":"121","author":"J Yang","year":"2014","unstructured":"Yang J (2014) Enhanced skeletal muscle for effective glucose homeostasis. Prog Mol Biol Transl Sci 121:133\u2013163","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"2335_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0165-2478(96)02572-2","volume":"52","author":"S Yamagoe","year":"1996","unstructured":"Yamagoe S, Yamakawa Y, Matsuo Y, Minowada J, Mizuno S, Suzuki K (1996) Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett 52(1):9\u201313","journal-title":"Immunol Lett"},{"issue":"37","key":"2335_CR115","doi-asserted-by":"publisher","first-page":"22657","DOI":"10.1074\/jbc.271.37.22657","volume":"271","author":"Y Hiraki","year":"1996","unstructured":"Hiraki Y, Inoue H, Kondo J, Kamizono A, Yoshitake Y, Shukunami C et al (1996) A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II: purification and amino acid sequence. J Biol Chem 271(37):22657\u201322662","journal-title":"J Biol Chem"},{"issue":"4","key":"2335_CR116","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/cts.12469","volume":"10","author":"V Slowik","year":"2017","unstructured":"Slowik V, Apte U (2017) Leukocyte cell-derived Chemotaxin-2: it\u2019s role in pathophysiology and future in Clinical Medicine. Clin Transl Sci 10(4):249\u2013259","journal-title":"Clin Transl Sci"},{"issue":"11","key":"2335_CR117","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1440-1827.1998.tb03855.x","volume":"48","author":"H Nagal","year":"1998","unstructured":"Nagal H, Hamada T, Uchida T, Yamagoe S, Suzuki K (1998) Systemic expression of a newly recognized protein, LECT2, in the human body. Pathol Int 48(11):882\u2013886","journal-title":"Pathol Int"},{"issue":"1","key":"2335_CR118","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0167-4781(97)00181-4","volume":"1396","author":"S Yamagoe","year":"1998","unstructured":"Yamagoe S, Mizuno S, Suzuki K (1998) Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver. Biochim Biophys Acta 1396(1):105\u2013113","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2335_CR119","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1507\/endocrj.EJ19-0255","volume":"66","author":"H Misu","year":"2019","unstructured":"Misu H (2019) Identification of hepatokines involved in pathology of type 2 diabetes and obesity. Endocr J 66(8):659\u2013662","journal-title":"Endocr J"},{"issue":"5","key":"2335_CR120","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2337\/db13-0728","volume":"63","author":"F Lan","year":"2014","unstructured":"Lan F, Misu H, Chikamoto K, Takayama H, Kikuchi A, Mohri K et al (2014) LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance. Diabetes 63(5):1649\u20131664","journal-title":"Diabetes"},{"key":"2335_CR121","doi-asserted-by":"publisher","first-page":"1158083","DOI":"10.3389\/fimmu.2023.1158083","volume":"14","author":"M-H Zhu","year":"2023","unstructured":"Zhu M-H, Liu Y-J, Yang G-J, Chen J (2023) The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: from mechanisms to therapeutic potential. Front Immunol 14:1158083","journal-title":"Front Immunol"},{"issue":"1","key":"2335_CR122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0167-4781(00)00056-7","volume":"1492","author":"H Hara","year":"2000","unstructured":"Hara H, Uchida S, Yoshimura H, Aoki M, Toyoda Y, Sakai Y et al (2000) Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim Biophys Acta 1492(1):31\u201344","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2335_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-4781(01)00249-4","volume":"1520","author":"H Hara","year":"2001","unstructured":"Hara H, Yoshimura H, Uchida S, Toyoda Y, Aoki M, Sakai Y et al (2001) Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity. Biochim Biophys Acta 1520(1):45\u201353","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2335_CR124","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/jcb.23202","volume":"112","author":"MM Cao","year":"2011","unstructured":"Cao MM, Xu WX, Li CY, Cao CZ, Wang ZD, Yao JW et al (2011) Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms. J Cell Biochem 112(10):2882\u20132890","journal-title":"J Cell Biochem"},{"issue":"3","key":"2335_CR125","doi-asserted-by":"publisher","first-page":"e58084","DOI":"10.1371\/journal.pone.0058084","volume":"8","author":"V Demchev","year":"2013","unstructured":"Demchev V, Malana G, Vangala D, Stoll J, Desai A, Kang HW et al (2013) Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization. PLoS ONE 8(3):e58084","journal-title":"PLoS ONE"},{"issue":"1","key":"2335_CR126","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/biof.1574","volume":"46","author":"RL Huang","year":"2020","unstructured":"Huang RL, Li CH, Du YF, Cheng KP, Lin CH, Hu CY et al (2020) Discovery of a role of the novel hepatokine, hepassocin, in obesity. BioFactors 46(1):100\u2013105","journal-title":"BioFactors"},{"issue":"2","key":"2335_CR127","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1096\/fj.201901925R","volume":"34","author":"HT Wu","year":"2020","unstructured":"Wu HT, Chen SC, Fan KC, Kuo CH, Lin SY, Wang SH et al (2020) Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity. Faseb j 34(2):2958\u20132967","journal-title":"Faseb j"},{"issue":"5","key":"2335_CR128","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jhep.2013.06.004","volume":"59","author":"HT Wu","year":"2013","unstructured":"Wu HT, Lu FH, Ou HY, Su YC, Hung HC, Wu JS et al (2013) The role of hepassocin in the development of non-alcoholic fatty liver disease. J Hepatol 59(5):1065\u20131072","journal-title":"J Hepatol"},{"issue":"8","key":"2335_CR129","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-016-3991-7","volume":"59","author":"HT Wu","year":"2016","unstructured":"Wu HT, Ou HY, Hung HC, Su YC, Lu FH, Wu JS et al (2016) A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia 59(8):1732\u20131742","journal-title":"Diabetologia"},{"key":"2335_CR130","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2017.10.014","volume":"470","author":"TW Jung","year":"2018","unstructured":"Jung TW, Chung YH, Kim HC, Abd El-Aty AM, Jeong JH (2018) Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Mol Cell Endocrinol 470:26\u201333","journal-title":"Mol Cell Endocrinol"},{"issue":"17","key":"2335_CR131","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.1111\/febs.16430","volume":"289","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liu X, Chen H, Wang P, Yao S, Zhou B et al (2022) HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis. Febs j 289(17):5279\u20135304","journal-title":"Febs j"},{"issue":"41","key":"2335_CR132","doi-asserted-by":"publisher","first-page":"37977","DOI":"10.1074\/jbc.M203830200","volume":"277","author":"C Vannahme","year":"2002","unstructured":"Vannahme C, Smyth N, Miosge N, G\u00f6sling S, Frie C, Paulsson M et al (2002) Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J Biol Chem 277(41):37977\u201337986","journal-title":"J Biol Chem"},{"issue":"5","key":"2335_CR133","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","volume":"14","author":"P Bornstein","year":"2002","unstructured":"Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14(5):608\u2013616","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"2335_CR134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pep.2008.07.009","volume":"62","author":"M Novinec","year":"2008","unstructured":"Novinec M, Kovacic L, Skrlj N, Turk V, Lenarcic B (2008) Recombinant human SMOCs produced by in vitro refolding: calcium-binding properties and interactions with serum proteins. Protein Expr Purif 62(1):75\u201382","journal-title":"Protein Expr Purif"},{"issue":"9","key":"2335_CR135","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1093\/nar\/gkq052","volume":"38","author":"R Di Niro","year":"2010","unstructured":"Di Niro R, Sulic AM, Mignone F, D\u2019Angelo S, Bordoni R, Iacono M et al (2010) Rapid interactome profiling by massive sequencing. Nucleic Acids Res 38(9):e110","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2335_CR136","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.matbio.2011.02.001","volume":"30","author":"F Brellier","year":"2011","unstructured":"Brellier F, Ruggiero S, Zwolanek D, Martina E, Hess D, Brown-Luedi M et al (2011) SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors. Matrix Biol 30(3):225\u2013233","journal-title":"Matrix Biol"},{"issue":"2","key":"2335_CR137","doi-asserted-by":"publisher","first-page":"e56839","DOI":"10.1371\/journal.pone.0056839","volume":"8","author":"M Klemen\u010di\u010d","year":"2013","unstructured":"Klemen\u010di\u010d M, Novinec M, Maier S, Hartmann U, Lenar\u010di\u010d B (2013) The heparin-binding activity of secreted modular calcium-binding protein 1 (SMOC-1) modulates its cell adhesion properties. PLoS ONE 8(2):e56839","journal-title":"PLoS ONE"},{"key":"2335_CR138","doi-asserted-by":"crossref","unstructured":"Montgomery MK, Bayliss J, Devereux C, Bezawork-Geleta A, Roberts D, Huang C et al (2020) SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Sci Transl Med. ;12(559)","DOI":"10.1126\/scitranslmed.aaz8048"},{"issue":"20","key":"2335_CR139","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1097\/CM9.0000000000000472","volume":"132","author":"Q Gao","year":"2019","unstructured":"Gao Q, Mok H-P, Zhuang J (2019) Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development. Chin Med J 132(20):2476\u20132484","journal-title":"Chin Med J"},{"issue":"1","key":"2335_CR140","doi-asserted-by":"publisher","first-page":"e0170083","DOI":"10.1371\/journal.pone.0170083","volume":"12","author":"L Decourtye","year":"2017","unstructured":"Decourtye L, Mire E, Clemessy M, Heurtier V, Ledent T, Robinson IC et al (2017) IGF-1 induces GHRH Neuronal Axon Elongation during early postnatal life in mice. PLoS ONE 12(1):e0170083","journal-title":"PLoS ONE"},{"issue":"6","key":"2335_CR141","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1172\/JCI0215463","volume":"110","author":"S Yakar","year":"2002","unstructured":"Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL et al (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110(6):771\u2013781","journal-title":"J Clin Invest"},{"issue":"12","key":"2335_CR142","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa022926","volume":"349","author":"EM Kofoed","year":"2003","unstructured":"Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J et al (2003) Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349(12):1139\u20131147","journal-title":"N Engl J Med"},{"issue":"8","key":"2335_CR143","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1172\/JCI118982","volume":"98","author":"K Rajkumar","year":"1996","unstructured":"Rajkumar K, Krsek M, Dheen ST, Murphy LJ (1996) Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Investig 98(8):1818\u20131825","journal-title":"J Clin Investig"},{"issue":"9319","key":"2335_CR144","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","volume":"359","author":"MS Sandhu","year":"2002","unstructured":"Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359(9319):1740\u20131745","journal-title":"Lancet"},{"issue":"10","key":"2335_CR145","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.numecd.2008.12.011","volume":"19","author":"E Succurro","year":"2009","unstructured":"Succurro E, Andreozzi F, Marini MA, Lauro R, Hribal ML, Perticone F et al (2009) Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. Nutr Metab Cardiovasc Dis 19(10):713\u2013719","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"20","key":"2335_CR146","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1161\/01.CIR.0000074249.75310.65","volume":"107","author":"RH Boger","year":"2003","unstructured":"Boger RH, Frystyk J, Ledet T, Moller N, Flyvbjerg A, Orskov H (2003) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease. Circulation 107(20):e193 author reply e","journal-title":"Circulation"},{"issue":"8","key":"2335_CR147","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1172\/JCI118982","volume":"98","author":"K Rajkumar","year":"1996","unstructured":"Rajkumar K, Krsek M, Dheen ST, Murphy LJ (1996) Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98(8):1818\u20131825","journal-title":"J Clin Invest"},{"issue":"1","key":"2335_CR148","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0169-328X(91)90054-2","volume":"10","author":"MA Bach","year":"1991","unstructured":"Bach MA, Shen-Orr Z, Lowe WL Jr., Roberts CT Jr., LeRoith D (1991) Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Brain Res Mol Brain Res 10(1):43\u201348","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"2335_CR149","doi-asserted-by":"publisher","first-page":"e1639","DOI":"10.1371\/journal.pone.0001639","volume":"3","author":"JY Lee","year":"2008","unstructured":"Lee JY, Muenzberg H, Gavrilova O, Reed JA, Berryman D, Villanueva EC et al (2008) Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PLoS ONE 3(2):e1639","journal-title":"PLoS ONE"},{"issue":"12","key":"2335_CR150","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41387-017-0002-0","volume":"7","author":"H Hong","year":"2017","unstructured":"Hong H, Cui ZZ, Zhu L, Fu SP, Rossi M, Cui YH et al (2017) Central IGF1 improves glucose tolerance and insulin sensitivity in mice. Nutr Diabetes 7(12):2","journal-title":"Nutr Diabetes"},{"issue":"1","key":"2335_CR151","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1152\/ajpregu.00344.2016","volume":"312","author":"NL Nguyen","year":"2017","unstructured":"Nguyen NL, Barr CL, Ryu V, Cao Q, Xue B, Bartness TJ (2017) Separate and shared sympathetic outflow to white and brown fat coordinately regulates thermoregulation and beige adipocyte recruitment. Am J Physiol Regul Integr Comp Physiol 312(1):R132\u2013r45","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2335_CR152","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2016.12.014","volume":"134","author":"ML Bonet","year":"2017","unstructured":"Bonet ML, Mercader J, Palou A (2017) A nutritional perspective on UCP1-dependent thermogenesis. Biochimie 134:99\u2013117","journal-title":"Biochimie"},{"issue":"12","key":"2335_CR153","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1210\/jcem.84.12.6255","volume":"84","author":"Z Laron","year":"1999","unstructured":"Laron Z (1999) The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 84(12):4397\u20134404","journal-title":"J Clin Endocrinol Metab"},{"issue":"10 Suppl 4","key":"2335_CR154","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0026-0495(95)90231-7","volume":"44","author":"Z Laron","year":"1995","unstructured":"Laron Z, Avitzur Y, Klinger B (1995) Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 44(10 Suppl 4):113\u2013118","journal-title":"Metabolism"},{"issue":"9","key":"2335_CR155","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1007\/s11695-020-04473-9","volume":"30","author":"X Wang","year":"2020","unstructured":"Wang X, Sun H, Ma B, Gao J, Yin J, Qu S (2020) Insulin-like growth factor 1 related to chronic low-grade inflammation in patients with obesity and early change of its levels after laparoscopic sleeve gastrectomy. Obes Surg 30(9):3326\u20133332","journal-title":"Obes Surg"},{"key":"2335_CR156","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH (2020) Growth\/Differentiation Factor-15 (GDF-15): from biomarker to Novel Targetable Immune Checkpoint. Front Immunol 11:951","journal-title":"Front Immunol"},{"issue":"11","key":"2335_CR157","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR et al (2007) Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 13(11):1333\u20131340","journal-title":"Nat Med"},{"key":"2335_CR158","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit SN, Brown DA, Tsai VW (2021) The GDF15-GFRAL pathway in Health and Metabolic Disease: friend or foe? Annu Rev Physiol 83:127\u2013151","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"2335_CR159","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2008.11.013","volume":"277","author":"JA Kelly","year":"2009","unstructured":"Kelly JA, Lucia MS, Lambert JR (2009) p53 controls prostate-derived factor\/macrophage inhibitory cytokine\/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms. Cancer Lett 277(1):38\u201347","journal-title":"Cancer Lett"},{"issue":"9","key":"2335_CR160","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/jcmm.17725","volume":"27","author":"M Asrih","year":"2023","unstructured":"Asrih M, Wei S, Nguyen TT, Yi HS, Ryu D, Gariani K (2023) Overview of growth differentiation factor 15 in metabolic syndrome. J Cell Mol Med 27(9):1157\u20131167","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2335_CR161","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis K, Wang X, Kosak J, Lee SH, Kim JS, Foley JF et al (2014) NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond) 38(12):1555\u20131564","journal-title":"Int J Obes (Lond)"},{"key":"2335_CR162","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/B978-0-12-407766-9.00015-8","volume":"91","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Rui L (2013) Lipocalin 13 regulation of glucose and lipid metabolism in obesity. Vitamins Horm 91:369\u2013383","journal-title":"Vitamins Horm"},{"key":"2335_CR163","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/B978-0-12-407766-9.00015-8","volume":"91","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Rui L (2013) Lipocalin 13 regulation of glucose and lipid metabolism in obesity. Vitam Horm 91:369\u2013383","journal-title":"Vitam Horm"},{"issue":"3","key":"2335_CR164","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/MCB.00459-10","volume":"31","author":"KW Cho","year":"2011","unstructured":"Cho KW, Zhou Y, Sheng L, Rui L (2011) Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol Cell Biol 31(3):450\u2013457","journal-title":"Mol Cell Biol"},{"issue":"44","key":"2335_CR165","doi-asserted-by":"publisher","first-page":"38128","DOI":"10.1074\/jbc.M111.256677","volume":"286","author":"L Sheng","year":"2011","unstructured":"Sheng L, Cho KW, Zhou Y, Shen H, Rui L (2011) Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid \u03b2-oxidation. J Biol Chem 286(44):38128\u201338135","journal-title":"J Biol Chem"},{"issue":"1","key":"2335_CR166","doi-asserted-by":"publisher","first-page":"13267","DOI":"10.1038\/ncomms13267","volume":"7","author":"B Ekim \u00dcst\u00fcnel","year":"2016","unstructured":"Ekim \u00dcst\u00fcnel B, Friedrich K, Maida A, Wang X, Krones-Herzig A, Seibert O et al (2016) Control of diabetic hyperglycaemia and insulin resistance through TSC22D4. Nat Commun 7(1):13267","journal-title":"Nat Commun"},{"issue":"1","key":"2335_CR167","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12079-018-0452-8","volume":"12","author":"SAI Ahmad","year":"2018","unstructured":"Ahmad SAI, Anam MB, Ito N, Ohta K (2018) Involvement of Tsukushi in diverse developmental processes. J Cell Communication Signal 12(1):205\u2013210","journal-title":"J Cell Communication Signal"},{"issue":"4","key":"2335_CR168","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12079-022-00669-z","volume":"16","author":"A Istiaq","year":"2022","unstructured":"Istiaq A, Ohta K (2022) A review on Tsukushi: mammalian development, disorders, and therapy. J Cell Communication Signal 16(4):505\u2013513","journal-title":"J Cell Communication Signal"},{"key":"2335_CR169","doi-asserted-by":"crossref","unstructured":"Mouchiroud M, Camir\u00e9 \u00c9, Aldow M, Caron A, Jubinville \u00c9, Turcotte L et al (2019) The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. JCI Insight. ;4(15)","DOI":"10.1172\/jci.insight.129492"},{"key":"2335_CR170","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s42255-018-0020-9","volume":"1","author":"Q Wang","year":"2019","unstructured":"Wang Q, Sharma V, Shen H, Xiao Y, Zhu Q, Xiong X et al (2019) The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation. Nat Metab 1:251\u2013260","journal-title":"Nat Metab"},{"issue":"2","key":"2335_CR171","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s42255-018-0020-9","volume":"1","author":"Q Wang","year":"2019","unstructured":"Wang Q, Sharma VP, Shen H, Xiao Y, Zhu Q, Xiong X et al (2019) The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation. Nat Metab 1(2):251\u2013260","journal-title":"Nat Metab"},{"key":"2335_CR172","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.molmet.2019.09.014","volume":"30","author":"M Mouchiroud","year":"2019","unstructured":"Mouchiroud M, Camir\u00e9 \u00c9, Aldow M, Caron A, Jubinville \u00c9, Turcotte L et al (2019) The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis. Mol Metab 30:184\u2013191","journal-title":"Mol Metab"},{"key":"2335_CR173","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","volume":"56","author":"S Aydin","year":"2014","unstructured":"Aydin S (2014) Three new players in energy regulation: preptin, adropin and irisin. Peptides 56:94\u2013110","journal-title":"Peptides"},{"key":"2335_CR174","doi-asserted-by":"crossref","unstructured":"Ali II, D\u2019Souza C, Singh J, Adeghate E (2022) Adropin\u2019s Role in Energy Homeostasis and Metabolic Disorders. Int J Mol Sci. ;23(15)","DOI":"10.3390\/ijms23158318"},{"issue":"6","key":"2335_CR175","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","volume":"8","author":"KG Kumar","year":"2008","unstructured":"Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN et al (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8(6):468\u2013481","journal-title":"Cell Metab"},{"key":"2335_CR176","doi-asserted-by":"crossref","unstructured":"Jasaszwili M, Billert M, Strowski MZ, Nowak KW, Skrzypski M (2020) Adropin as a Fat-Burning hormone with multiple functions-review of a Decade of Research. Molecules. ;25(3)","DOI":"10.3390\/molecules25030549"},{"issue":"7","key":"2335_CR177","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2012.31","volume":"20","author":"K Ganesh Kumar","year":"2012","unstructured":"Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH et al (2012) Adropin deficiency is associated with increased adiposity and insulin resistance. Obes (Silver Spring) 20(7):1394\u20131402","journal-title":"Obes (Silver Spring)"},{"issue":"40","key":"2335_CR178","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1074\/jbc.RA120.014381","volume":"295","author":"S Banerjee","year":"2020","unstructured":"Banerjee S, Ghoshal S, Stevens JR, McCommis KS, Gao S, Castro-Sepulveda M et al (2020) Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction. J Biol Chem 295(40):13753\u201313768","journal-title":"J Biol Chem"},{"issue":"4","key":"2335_CR179","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmet.2015.01.005","volume":"4","author":"S Gao","year":"2015","unstructured":"Gao S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA (2015) Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab 4(4):310\u2013324","journal-title":"Mol Metab"},{"issue":"3","key":"2335_CR180","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/molecules25030549","volume":"25","author":"M Jasaszwili","year":"2020","unstructured":"Jasaszwili M, Billert M, Strowski MZ, Nowak KW, Skrzypski M (2020) Adropin as a fat-burning hormone with multiple functions\u2014review of a decade of research. Molecules 25(3):549","journal-title":"Molecules"},{"key":"2335_CR181","doi-asserted-by":"crossref","unstructured":"Takanori Nakamura MA, Yuzuru EI, Takio K, Uchiyama H, Moriya N, Ariizumi T (1992) Takayuki Yashiro, Kishiko Sugino, Koiti Titani, and Hiromu Sugino. Isolation and Characterization of Native Activin B","DOI":"10.1016\/S0021-9258(18)42014-5"},{"issue":"2","key":"2335_CR182","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2005.12.205","volume":"341","author":"O Hashimoto","year":"2006","unstructured":"Hashimoto O, Ushiro Y, Sekiyama K, Yamaguchi O, Yoshioka K, Mutoh K et al (2006) Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. Biochem Biophys Res Commun 341(2):416\u2013424","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2335_CR183","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/08977190410001704688","volume":"22","author":"Y Abe","year":"2004","unstructured":"Abe Y, Minegishi T, Leung PC (2004) Activin receptor signaling. Growth Factors 22(2):105\u2013110","journal-title":"Growth Factors"},{"issue":"2","key":"2335_CR184","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/ATVBAHA.122.318138","volume":"43","author":"H Liu","year":"2023","unstructured":"Liu H, Hallauer Hastings M, Kitchen R, Xiao C, Baldovino Guerra JR, Kuznetsov A, Arteriosclerosis et al (2023) Thromb Vascular Biology 43(2):330\u2013349","journal-title":"Thromb Vascular Biology"},{"issue":"1\u20132","key":"2335_CR185","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0303-7207(02)00157-0","volume":"194","author":"O Hashimoto","year":"2002","unstructured":"Hashimoto O, Tsuchida K, Ushiro Y, Hosoi Y, Hoshi N, Sugino H et al (2002) cDNA cloning and expression of human activin betaE subunit. Mol Cell Endocrinol 194(1\u20132):117\u2013122","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2335_CR186","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2018.10.008","volume":"25","author":"O Hashimoto","year":"2018","unstructured":"Hashimoto O, Funaba M, Sekiyama K, Doi S, Shindo D, Satoh R et al (2018) Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine. Cell Rep 25(5):1193\u20131203","journal-title":"Cell Rep"},{"issue":"5","key":"2335_CR187","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1292\/jvms.19-0036","volume":"81","author":"K Sekiyama","year":"2019","unstructured":"Sekiyama K, Ushiro Y, Kurisaki A, Funaba M, Hashimoto O (2019) Activin E enhances insulin sensitivity and thermogenesis by activating brown\/beige adipocytes. J Vet Med Sci 81(5):646\u2013652","journal-title":"J Vet Med Sci"},{"issue":"2","key":"2335_CR188","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diabet.2019.05.005","volume":"46","author":"S Smati","year":"2020","unstructured":"Smati S, R\u00e9gnier M, Fougeray T, Polizzi A, Fougerat A, Lasserre F et al (2020) Regulation of hepatokine gene expression in response to fasting and feeding: influence of PPAR-\u03b1 and insulin-dependent signalling in hepatocytes. Diabetes Metab 46(2):129\u2013136","journal-title":"Diabetes Metab"},{"issue":"5","key":"2335_CR189","first-page":"152","volume":"77","author":"H Ko","year":"2022","unstructured":"Ko H, Il Kim Y, Ahn HJ (2022) Activin suppresses the inflammatory response of TNF-\u03b1-stimulated human umbilical vein endothelial cells. Die Pharmazie-An Int J Pharm Sci 77(5):152\u2013156","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"issue":"6","key":"2335_CR190","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3325\/cmj.2012.53.535","volume":"53","author":"RL Schmidt","year":"2012","unstructured":"Schmidt RL, Simonovi\u0107 M (2012) Synthesis and decoding of selenocysteine and human health. Croat Med J 53(6):535\u2013550","journal-title":"Croat Med J"},{"issue":"1","key":"2335_CR191","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12933-017-0585-8","volume":"16","author":"S-s Yu","year":"2017","unstructured":"Yu S-s, Du J-l (2017) Selenoprotein S: a therapeutic target for diabetes and macroangiopathy? Cardiovasc Diabetol 16(1):101","journal-title":"Cardiovasc Diabetol"},{"key":"2335_CR192","doi-asserted-by":"crossref","unstructured":"Arteel GE, Klotz L-O, Buchczyk DP, Sies H (2002) [11] - selenoprotein P. In: Sies H, Packer L (eds) Methods in Enzymology, vol 347. Academic, pp 121\u2013125","DOI":"10.1016\/S0076-6879(02)47013-9"},{"issue":"1","key":"2335_CR193","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13098-023-01247-y","volume":"16","author":"S-s Yu","year":"2024","unstructured":"Yu S-s, Du J-l (2024) Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers. Diabetol Metab Syndr 16(1):5","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2335_CR194","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s42000-019-00127-3","volume":"19","author":"SA Polyzos","year":"2020","unstructured":"Polyzos SA, Kountouras J, Goulas A, Duntas L (2020) Selenium and selenoprotein P in nonalcoholic fatty liver disease. Horm (Athens) 19(1):61\u201372","journal-title":"Horm (Athens)"},{"issue":"1","key":"2335_CR195","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1074\/jbc.M113.479386","volume":"289","author":"H Takayama","year":"2014","unstructured":"Takayama H, Misu H, Iwama H, Chikamoto K, Saito Y, Murao K et al (2014) Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)\/FoxO3a pathway in H4IIEC3 hepatocytes. J Biol Chem 289(1):335\u2013345","journal-title":"J Biol Chem"},{"key":"2335_CR196","doi-asserted-by":"crossref","unstructured":"Ye R, Huang J, Wang Z, Chen Y, Dong Y (2022) The role and mechanism of essential selenoproteins for Homeostasis. Antioxid (Basel). ;11(5)","DOI":"10.3390\/antiox11050973"},{"issue":"5","key":"2335_CR197","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","volume":"12","author":"H Misu","year":"2010","unstructured":"Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S et al (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12(5):483\u2013495","journal-title":"Cell Metab"},{"issue":"8","key":"2335_CR198","doi-asserted-by":"publisher","first-page":"E1325","DOI":"10.1210\/jc.2011-0620","volume":"96","author":"SJ Yang","year":"2011","unstructured":"Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG et al (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 96(8):E1325\u2013E1329","journal-title":"J Clin Endocrinol Metab"},{"key":"2335_CR199","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10787-020-00690-x","volume":"28","author":"S Hariharan","year":"2020","unstructured":"Hariharan S, Dharmaraj S (2020) Selenium and selenoproteins: it\u2019s role in regulation of inflammation. Inflammopharmacology 28:667\u2013695","journal-title":"Inflammopharmacology"},{"key":"2335_CR200","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s42000-019-00127-3","volume":"19","author":"SA Polyzos","year":"2020","unstructured":"Polyzos SA, Kountouras J, Goulas A, Duntas L (2020) Selenium and selenoprotein P in nonalcoholic fatty liver disease. Hormones 19:61\u201372","journal-title":"Hormones"},{"issue":"10","key":"2335_CR201","first-page":"7520","volume":"14","author":"HA Alfawaz","year":"2022","unstructured":"Alfawaz HA, Alfaifi AA, Yakout SM, Khattak MNK, Alnaami AM, Al-Thayidi A et al (2022) Circulating hepcidin and its associations with low-grade inflammation and iron indices among arab adults with and without T2DM. Am J Translational Res 14(10):7520","journal-title":"Am J Translational Res"},{"key":"2335_CR202","unstructured":"Chambers K, Ashraf MA, Sharma S (2019) Physiology, hepcidin"},{"issue":"3","key":"2335_CR203","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J (2023) Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis 14(3):186","journal-title":"Cell Death Dis"},{"issue":"1","key":"2335_CR204","doi-asserted-by":"publisher","first-page":"98","DOI":"10.18585\/inabj.v14i1.1780","volume":"14","author":"M Maherdika","year":"2022","unstructured":"Maherdika M, Samsuria IK, Hendrianingtyas M, Widyastiti NS, Rahayu M (2022) The difference levels of hepcidin and interleukin-6 between obese and non-obese type 2 diabetes mellitus. Indonesian Biomedical J 14(1):98\u2013103","journal-title":"Indonesian Biomedical J"},{"key":"2335_CR205","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molimm.2021.02.015","volume":"133","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang L, Tan Y-m, Liu Y-p, Li J-j, Deng Q-m et al (2021) Hepcidin gene silencing ameliorated inflammation and insulin resistance in adipose tissue of db\/db mice via inhibiting METs formation. Mol Immunol 133:110\u2013121","journal-title":"Mol Immunol"},{"key":"2335_CR206","doi-asserted-by":"publisher","first-page":"107092","DOI":"10.1016\/j.diabres.2017.10.004","volume":"156","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Liu H, Liu J (2019) Akt activation: a potential strategy to ameliorate insulin resistance. Diabetes Res Clin Pract 156:107092","journal-title":"Diabetes Res Clin Pract"},{"key":"2335_CR207","doi-asserted-by":"publisher","first-page":"115397","DOI":"10.1016\/j.jep.2022.115397","volume":"295","author":"X-g Zhang","year":"2022","unstructured":"Zhang X-g, Liu A-x, Zhang Y-x, Zhou M-y, Li X-y, Fu M-h et al (2022) A diarylheptanoid compound from alpinia officinarum hance ameliorates high glucose-induced insulin resistance by regulating pi3k\/akt-nrf2-gsk3\u03b2 signaling pathways in hepg2 cells. J Ethnopharmacol 295:115397","journal-title":"J Ethnopharmacol"},{"key":"2335_CR208","doi-asserted-by":"crossref","unstructured":"Mo M, Pan L, Deng L, Liang M, Xia N, Liang Y (2024) Iron Overload induces hepatic ferroptosis and insulin resistance by inhibiting the Jak2\/stat3\/slc7a11 signaling pathway. Cell Biochem Biophys. :1\u201316","DOI":"10.1007\/s12013-024-01315-8"},{"key":"2335_CR209","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ygcen.2017.08.023","volume":"260","author":"L Lu","year":"2018","unstructured":"Lu L, Ye X, Yao Q, Lu A, Zhao Z, Ding Y et al (2018) Egr2 enhances insulin resistance via JAK2\/STAT3\/SOCS-1 pathway in HepG2 cells treated with palmitate. Gen Comp Endocrinol 260:25\u201331","journal-title":"Gen Comp Endocrinol"},{"key":"2335_CR210","doi-asserted-by":"publisher","first-page":"247054702210763","DOI":"10.1177\/24705470221076390","volume":"6","author":"M Page","year":"2022","unstructured":"Page M, Kell D, Pretorius E (2022) The role of lipopolysaccharide-induced cell signalling in chronic inflammation. Chronic Stress (Thousand Oaks) 6:24705470221076390","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"2335_CR211","doi-asserted-by":"publisher","first-page":"681810","DOI":"10.3389\/fimmu.2021.681810","volume":"12","author":"L Meng","year":"2021","unstructured":"Meng L, Song Z, Liu A, Dahmen U, Yang X, Fang H (2021) Effects of lipopolysaccharide-binding protein (LBP) single nucleotide polymorphism (SNP) in infections, inflammatory diseases, metabolic disorders and cancers. Front Immunol 12:681810","journal-title":"Front Immunol"},{"key":"2335_CR212","doi-asserted-by":"publisher","first-page":"247054702210763","DOI":"10.1177\/24705470221076390","volume":"6","author":"MJ Page","year":"2022","unstructured":"Page MJ, Kell DB, Pretorius E (2022) The role of lipopolysaccharide-induced cell signalling in chronic inflammation. Chronic Stress 6:24705470221076390","journal-title":"Chronic Stress"},{"issue":"1","key":"2335_CR213","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/prd.12433","volume":"89","author":"PJ Pussinen","year":"2022","unstructured":"Pussinen PJ, Kopra E, Pieti\u00e4inen M, Lehto M, Zaric S, Paju S et al (2022) Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia. Periodontol 2000 89(1):19\u201340","journal-title":"Periodontol 2000"},{"key":"2335_CR214","doi-asserted-by":"crossref","unstructured":"Liu J, Kang R, Tang D (2024) Lipopolysaccharide delivery systems in innate immunity. Trends Immunol","DOI":"10.1016\/j.it.2024.02.003"},{"issue":"2","key":"2335_CR215","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ijms21020379","volume":"21","author":"L Mazgaeen","year":"2020","unstructured":"Mazgaeen L, Gurung P (2020) Recent advances in lipopolysaccharide recognition systems. Int J Mol Sci 21(2):379","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2335_CR216","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.3390\/ijms221910460","volume":"22","author":"L Frances","year":"2021","unstructured":"Frances L, Tavernier G, Viguerie N (2021) Adipose-derived lipid-binding proteins: the good, the bad and the metabolic diseases. Int J Mol Sci 22(19):10460","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2335_CR217","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.41679","volume":"73","author":"Y Won","year":"2021","unstructured":"Won Y, Yang JI, Park S, Chun JS (2021) Lipopolysaccharide binding protein and CD14, cofactors of toll-like receptors, are essential for low\u2010Grade inflammation\u2013Induced exacerbation of cartilage damage in mouse models of Posttraumatic Osteoarthritis. Arthritis Rheumatol 73(8):1451\u20131460","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"2335_CR218","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM (2020) Metabolic inflammation and insulin resistance in obesity. Circul Res 126(11):1549\u20131564","journal-title":"Circul Res"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02335-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:02:18Z","timestamp":1730516538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02335-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":218,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02335-9","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}